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Abstract 16 
In the emerging field of wastewater-based epidemiology (WBE), temperature – a well-known, key factor, 17 
influencing the transformation kinetics of organic chemicals, has thus far been ignored in predicting 18 
chemical consumption rates in urban catchments. This is problematic as WBE data are collected from 19 
and compare sewer catchments with highly varying wastewater temperatures. 20 
In this study, we assessed, for the first time, the influence of temperature on the transformation of 21 
biomarker transformation in wastewater and its ensuing implications on the back-calculation of chemical 22 
consumption rate in urban catchments using the example of selected illicit drugs. Literature data, obtained 23 
in laboratory-scale experiments, on the stability of drug biomarkers in untreated wastewater – occurring 24 
at trace levels – was systematically reviewed, and transformation rates obtained at different temperatures 25 
were collected. Robust correlations, using the Arrhenius equation, were inferred to describe the 26 
transformation of selected cocaine and morphine biomarkers in environmentally relevant temperature 27 
ranges (from 2–9ºC to 30–31ºC), with estimated ϴ coefficients between 1.04 and 1.18. These 28 
empirically-derived relationships were used to assess the influence of temperature on the transformation 29 
of drug biomarkers during in-sewer transport and its effect on the back-calculation of drug consumption 30 
rate in synthetic urban catchment scenario simulations. As for quantifying the uncertainty of temperature 31 
effects, up to 4-fold increase in removal efficiency was estimated when wastewater temperature increased 32 
from 15 ºC to 25°C – a range representative, notably, to seasonal variations in continental urban 33 
catchments, e.g., Spain, where some of the highest drug consumption rates are observed in Europe. 34 
Findings from this study can help reducing the uncertainty intrinsic to wastewater-based epidemiology 35 
studies, and will be beneficial in comparing chemical consumption estimates from different catchments 36 
worldwide.  37 
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Highlights:  42 
 Assessing impacts of temperature on biomarker transformation and on WBE predictions. 43 
 Broad literature review on transformation rates combined with temperature data  44 
 Robust, Arrhenius-based correlation identified to account for temperature effects; described 45 
temperature-dependent transformation of biomarkers 46 
 Findings facilitate significant reduction of uncertainties in WBE assessment. comparative 47 
estimation of drug consumption in WBE studies  48 
 49 
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1. Introduction  53 
Wastewater-based epidemiology (WBE) is a growing research field to improve social behavior 54 
predictions in an epidemiological context. It is based on the analysis of substance residues (biomarkers) 55 
in wastewater and back-calculation of population consumption/exposure at catchment level. Substance 56 
use biomarkers, such as illicit drug abuse and exposure to pesticides, have been the main focus of WBE 57 
studies (Gracia-Lor et al., 2017). A number of uncertainties (e.g., chemical analysis, determination of 58 
catchment population) have been associated to the determination of community drug use (Castiglioni et 59 
al., 2013). Furthermore, neglecting in-sewer transformation can also be a significant source of bias since 60 
biomarker concentration levels at the excretion point can differ from the sampling point (Li et al., 2018). 61 
In-sewer stability of drugs is mainly associated to abiotic transformation (without the presence of 62 
biomass) and biotransformation in the presence of suspended and attached biomass.  63 
In WBE studies, two main approaches have been used to translate measured concentration to 64 
consumption rate: (i) lumped correction factors that include e.g., excretion ratios and in-sewer 65 
transformation; (ii) in-sewer process kinetic models together with excretion ratios. The first approach is 66 
commonly used due to its simplicity, with the major drawback of lacking catchment specificity. 67 
Conversely, process models explicitly rely on first- or second-order equations (McCall et al., 2016; Plósz 68 
et al., 2013; Ramin et al., 2016) to describe transformation kinetics, therefore allowing to account for a 69 
number of influencing factors (e.g. redox conditions, in-sewer residence time, transformation pathways 70 
and biomarker concentrations) depending on the complexity level. A factor known to influence microbial 71 
activity—hence biomarker stability—is temperature. The impact of temperature on the transformation of 72 
organic micropollutants has been assessed in activated sludge (Li et al., 2005) and in anaerobic digestion 73 
(Carballa et al., 2007). As to illicit drug biomarkers, stability studies in untreated wastewater (Bisceglia 74 
and Lippa, 2014; Devault et al., 2017) have overall revealed enhanced transformation kinetics with 75 
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increasing temperature. While the effect of temperature on microbial growth kinetics is considered in 76 
models for conventional pollutants (e.g., activated sludge models), very few examples exist on 77 
quantifying the temperature dependence of kinetic model parameters for trace organic chemical 78 
transformation (Li et al., 2005; Wick et al., 2009).  79 
In sewers, wastewater temperature exhibits seasonal and geographical variations and may further vary 80 
within the same catchment. During a recent Europe-wide sampling campaign (conducted simultaneously 81 
in 47 cities), the temperature of raw wastewater at sampling points was reported in the range between 7 82 
ºC and 28ºC (Ort et al., 2014). Consequently, the impact of temperature on the stability of drug 83 
biomarkers in sewers may significantly vary from catchment to catchment, and the associated 84 
uncertainties propagating to the back-calculated consumption rate could be reduced in WBE approaches 85 
using more robust temperature models – the main focal area chosen for this study. 86 
Considering existing limitations, the objectives of this study were: (i) to assess the effect of temperature 87 
on in-sewer drug biomarker stability, based on findings from published literature; (ii) Use empirical 88 
equations to describe temperature-dependent transformation kinetics of selected biomarkers in 89 
wastewater under aerobic conditions; (iii) to assess the influence of temperature on the in-sewer removal 90 
of drug biomarkers through synthetic urban catchment simulations.  91 
 92 
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2. Materials and methods 93 
2.1. Literature review and data treatment 94 
Published scientific literature was reviewed (last update: 31/03/2018) to select drug biomarker stability 95 
studies in untreated wastewater, i.e. without the influence of biofilm. Further screening for sound and 96 
rigorous literature evidences was performed using the following criteria: (i) stability studies were 97 
performed under aerobic conditions; (ii) biomarker transformation kinetics were explicitly reported or 98 
could be derived (calculated) based on presented results (e.g., concentration profiles in batch 99 
experiments); (iii) estimation of model parameters (see Eq. 1) was associated with good match between 100 
measured and predicted concentration profiles (R2>0.7). Ten literature studies were eventually selected 101 
(Table 1), providing relevant information on stability of cocaine (COC), ecgonine-methyl-ester (EME), 102 
cocaethylene (CE), norcocaine (NorCOC) and 6-monoacetylmorphine (6-MAM).  103 
The first-order transformation rate coefficient (k, d-1) was used as indicator of biomarker stability in 104 
wastewater. Notably, k accounts for both abiotic and biotransformation kinetics, given that abiotic control 105 
experiments were absent in most of the selected studies. When k values were not explicitly reported, they 106 
were estimated by fitting experimental data with a first-order kinetic equation (Eq. 1): 107 
C(t) = C0 e-kt         (Eq. 1) 108 
where C0 and C(t) are biomarker concentrations at time 0 and at time t, respectively.  109 
In two cases (McCall et al., 2016; Ramin et al., 2016), abiotic and biotransformation kinetics were 110 
separately assessed and quantified by estimating the first-order rate coefficients (kabio, d-1) and pseudo-111 
first-order rate coefficients (kbio, L g-1 d-1), respectively. The two kinetic indicators were combined to 112 
obtain k (Eq. 2): 113 
k = kabio + kbio XTSS        (Eq. 2)   114 
8 
where XTSS (g L-1) denotes the concentration of total suspended solids (TSS) in the experiments. Data 115 
from concentration profiles were extracted, when necessary, using the software PlotDigitizer (name of 116 
manufacturer, Country) 117 
For each biomarker, the Arrhenius equation (Eq. 3) was used to describe variations in transformation 118 
rates as a function of temperature: 119 
kT = k25 θ (T-25)        (Eq. 3)   120 
where T(ºC) denotes the temperature, at which a specific kT value was derived, k25 the transformation 121 
rate at 25ºC and θ (-) the exponential Arrhenius coefficient. Parameters θ and k25 were estimated for each 122 
biomarker using particle swarm optimization in MATLAB 2016b. A temperature of 25ºC was selected 123 
as reference to improve the identifiability of both estimated parameters, as previously suggested 124 
(Schwaab et al., 2007). 125 
<Table 1> 126 
2.2. Back-calculation procedure 127 
To back-calculate drug concentration at the release point e.g. after toilet flush (unknown), drug 128 
concentration at the influent of wastewater treatment plant (known) is considered in a hypothetical 129 
catchment. In-sewer transformation was simulated using Eq. 1 and assuming an average residence time 130 
of 4.5 h, corresponding to the average residence time in a recent European monitoring campaign (Ort et 131 
al., 2014).  132 
2.3. Parameter estimation and quantification of uncertainties 133 
Bayesian inference, employing prior knowledge in terms of model parameters, is employed to estimate 134 
ϴ parameter values using ???. Additionally, propagation of parameter uncertainty onto the back-135 
calculation results is quantified. Monte Carlo simulations of in-sewer biomarker transformation were 136 
9 
performed using prior parameter sets sampled using Latin Hypercube Sampling (LHS, Reference). To 137 
evaluate the impact of temperature on the removal of the selected drugs, three temperature conditions 138 
were considered, being representative of low (T=5°C), medium (T=15°C) and high (T=25°C) 139 
temperature.  140 
  141 
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3. Results and discussion 142 
3.1. Temperature-dependent transformation  143 
Considerable data variability in k rate values found in literature was noticed for most all selected drugs 144 
(Fig. 1), even considering the same temperature (e.g., 6-MAM) as a result of factors such as, differences 145 
in stability test conditions used in literature. Nevertheless, overall increase of k with increasing 146 
temperature was observed, especially when considering the mean of multiple measurements for each 147 
unique temperature. 148 
Additionally, for each biomarker, Fig. 1 presents plots of fitted Arrhenius equations (and associated 95% 149 
confidence intervals (CI), shaded areas). Interestingly, many of the calculated data points (not reported 150 
in the original study) and estimated ones (reported in the original study) fall out of the CI (almost 50% 151 
of all data points). A portion of data points were found to be inside the CI, namely McCall et al. (74%),  152 
Bisceglia and Lippa (67%), Mardal et al. (56%), Devault et al. (37%), Baker and Kasprzyk-Hordern 153 
(33%) and van Nuijs et al. (33%). Low transformation (hence below CI) in Senta et al. (2014) and Chen 154 
et al. (2013) could be due to limited oxygen availability in test setups, resulting in lower microbial activity 155 
(Table 1). Conversely, high transformation observed in Ramin et al. (2016) could have resulted from 156 
high oxygen levels (~ saturation) in test reactors, determining significant microbial growth during batch 157 
experiments. Beside oxygen levels, under- or over-estimation of k (d-1) values can be a consequence of 158 
the limited applicability of first-order kinetics to describe biomarker biotransformation, e.g. due to 159 
significant microbial growth or inhibition of biomass. This could be the case for Thai et al. data points 160 
which are placed both above and below CI. Moreover, partitioning of drug biomarkers to solid phases 161 
(suspended particles, reactor walls) are additional processes that need to be accounted for when 162 
estimating k (d-1) (Ramin et al., 2016).  163 
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Besides the previously discussed inherent data variability, this may have resulted from the limited 164 
applicability of first-order transformation kinetics e.g. due to significant microbial growth during batch 165 
experiments (Ramin et al., 2016).  166 
Estimated parameter values kT (d-1) and ϴ for the selected biomarkers are reported in Table 2. It can be 167 
noticed that the estimated relative error was low, below 50%, except for NorCOC (0.78%) and parameter 168 
collinearity was low expect for EME (-0.75). This seems to suggest good parameter identifiability, based 169 
on criteria (error < 50% and collinearity < 0.7) set by (Frutiger et al., 2016). Nevertheless, these 170 
thresholds are subjective and the consideration of 25°C as reference temperature allowed for the 171 
improvement of parameter identifiability (achieving lower correlation).  172 
Estimated ϴ coefficient values were between 1.04 and 1.18, in agreement with previously reported 173 
values. That is, for primary metabolic processes (relevant for biomass growth) in sewers, Arrhenius-174 
based temperature corrections have been suggested, with ϴ values of 1.07 and 1.05 for aerobic water 175 
phase and biofilm processes, respectively (Hvitved-Jacobsen et al., 2013). Henze et al. (2000) also 176 
suggested similar coefficients to describe temperature dependency of biological processes in the 177 
Activated sludge model No. 2 (ASM2). These coefficients are ranging from low (ϴ = 1.04) for hydrolysis 178 
to high (ϴ = 1.12) for nitrification. Similar ϴ values were also estimated for 17-β estradiol (E2) 179 
transformation by activated sludge, ranging from 1.03 to 1.09 for different biomass concentrations (Li et 180 
al., 2005). Wick et al. (2009) considered temperature-dependent biotransformation for successful 181 
prediction of season-dependent pharmaceutical and illicit drugs removal in WWTPs. The correction 182 
factor, ϴ, for organic micropollutants such as pharmaceuticals was estimated in the range of 1.03–1.09 183 
(Joss et al., 2006). Overall, previous and current findings demonstrate that temperature can have 184 
considerable impact on transformation, the extent of which is compound-dependent. 185 
 186 
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3.2. Influence of temperature on back-calculation of drug use 187 
As expected, higher temperature resulted in higher in-sewer removal, with 40% (6-MAM) to almost 4-188 
fold (EME) increase of removal efficiency from medium to high temperature. Consistently, 6-MAM and 189 
EME have lowest and highest ϴ values (Table 2).  190 
These results indicate that accounting for in-sewer transformation is important especially at elevated 191 
temperatures (above 15°C). Consequently, the temperature dependency of k should be accounted for 192 
explicitly in steady-state and dynamic model simulations. From this stand point, the Arrhenius equation 193 
can be included in existing modeling frameworks for removal of drug biomarkers in wastewater such as 194 
WATS—ASM-X (Ramin et al., 2016). We note that, in this study, the estimation of in-sewer removal 195 
was performed based on individual biomarkers, and the transformation of biomarkers into/from other 196 
biomarkers was neglected. It is common practice to back-calculate the consumption of COC based on 197 
the concentration of its metabolite benzoylecgonine (BE) and COC itself. It has been found that BE, 198 
beside formation, also under go transformation (McCall et al., 2016; Ramin et al., 2016), although some 199 
studies reported negligible in-sewer BE transformation (Bisceglia and Lippa, 2014; Thai et al., 2014). 200 
Further discussion on back-calculation of illicit drug consumption interested readers are referred to 201 
available literature (Castiglioni et al., 2013; Khan and Nicell, 2011).  202 
It is evident that further research is crucial for obtaining new evidence on drug stability at different 203 
temperatures, especially for new psychoactive substances. This is generally relevant for other types of 204 
biomarkers beyond illicit drugs, which wastewater-based epidemiologists have gained increasing interest 205 
in (Gracia-Lor et al., 2017). We encourage authors to report conditions at which stability tests were 206 
performed, similarly to Table 1. This would allow for better comparison and consistency evaluation 207 
among different studies. 208 
 209 
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4. Conclusions 210 
This study presents, for the first time, a comprehensive correlation analysis for the temperature 211 
dependence of transformation kinetics (abiotic and biotic) of biomarkers and quantifies its uncertainty 212 
implications on WBE back-calculation results. Five illicit drug biomarkers (COC, EME, CE, NorCOC, 213 
6-MAM) were used in untreated wastewater under aerobic conditions. Following conclusions are made: 214 
 Although affected by the considerable variability of measured transformation kinetics, the 215 
Arrhenius equation could capture trends of increasing transformation rates with increasing 216 
temperature within the applicability domain (from 2–9ºC to 30–31ºC).  217 
 Arrhenius-based equations were estimated for each biomarker and used for removal predictions 218 
during transport in ideal sewers. Up to almost 4-fold removal efficiency was observed when 219 
temperature was changed from 15 ºC to 25°C.  220 
 These findings have considerable implications for back-calculation of drug consumption based 221 
on the analysis of untreated wastewater influents, especially for multi-catchment studies covering 222 
wide geographical areas. Further research should extend the investigation of temperature effects 223 
to (i) a larger number biomarkers; (ii) anaerobic conditions; and (iii) sewer biofilms.  224 
 225 
 226 
 227 
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Figures 315 
 316 
Figure 1. Arrhenius equation fits for degradation rates k (d-1) as a function of temperature (ºC). These 317 
are based on the reported (full circles) and the estimated (empty circles) empirical values from literature. 318 
Lines are the best prediction and the shaded band is the 95% confidence interval of the prediction.   319 
20 
 320 
Figure 2. Estimated in-sewer removal (transformation) rates from excretion point to WWTP influent (in-321 
sewer residence time = 4.5 h) for selected drug biomarkers, calculated using the identified Arrhenius 322 
regression equations. Error bars represent 95% confidence interval following Monte Carlo simulation. 323 
Asterisks (*) indicates that the temperature is out of applicability range.   324 
21 
Table 1. Overview of selected biomarker stability studies from published literature.   325 
No. Reference Chemical Data source for extraction of k 
Temp. 
(ºC) pH 
DO 
(mg L-1) 
Duration of 
experiment 
(h) 
No. of 
samples 
taken 
C0  
(µg L-1) 
TSS 
(g L-1) 
1 (Baker and Kasprzyk-Hordern, 2011) 
COC, CE, 
6MAM, 
NorCOC 
Table 2, 19 7.4 - 72 4 1.0 - 
2 (van Nuijs et al., 2012) 
COC, EME, 
6MAM Graph 20 7.5 - 26 13 0.06–0.60 - 
3 (Chen et al., 2013) 6MAM Graph 4 7.4 - 336 6 >0.1 - 
4 (Bisceglia and Lippa, 2014) 
COC, EME, 
CE, NorCOC Values reported 
9, 23, 
31 7.4 - 26 16 1.5–3.0 - 
5 (Senta et al., 2014) COC, 6MAM Graph, values reported 20 7.5 - 72 7 0.2 - 
6 (Thai et al., 2014) COC, 6MAM Values reported 20 7.5 - 12 9 10 - 
7 (Mardal et al., 2016) COC, EME, CE Graph, Table 23 7-8 - 24 9 0.5-100 - 
8 (Ramin et al., 2016) COC, EME, CE, 6MAM Values reported  14 
8.6–
8.8 10 48 9 10 0.32 ± 0.04 
9 (McCall et al., 2016) 
COC, CE, 
6MAM, 
NorCOC 
Values reported  21 8.0–8.9 5–8 24 11 2.0–3.0 0.14–0.29 
10 (Devault et al., 2017) COC, 6MAM Values reported   20, 30 
6.6, 
7.6 - 24 7 1.0–3.0 - 
1Used silanized amber glass bottles stored in the dark. 
2Stability test performed in silanized glass flasks which were hand-shaken app. 10 times per hour. 
3Bottles at 20ºC were placed under fume cupboard uncapped and gently stirred 3 times per day (distilled water was used to compensate for evaporation). Bottle 
at 4ºC was stored with cap on.  
4Used Erlenmeyer flask equipped with foam stopper to allow air transfer. Reactor was shaken at 180 rpm in the dark.  
5Glass bottles were capped with cotton plugs and placed in a thermostated cabinet. 
6Used gravity sewer reactor with continuous mixing with magnetic stirrer (250 rpm) to enhance surface aeration.  
7Urinary samples collected at a music festival was dilutted with wastewater and incubated in a temperature water bath 
8Transformation study was performed in a covered jacketed reactor equipped with an agitator and oxygen diffuser.  
9Transformaiton study was conducted in Erlenmeyer flask on a shaker table in the dark. Autoclaved wastewater was chosen to represent abiotic transformation.   
10Glass bottles were placed in the dark and aerobic conditinos was maintained by shaking with a magnetic stir bar. 
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Table 2. Estimated kT25 (d-1) and θ and their correlation for the selected drugs. Parameters are estimated 327 
as the best fitted value together with 95% confidence interval. The predictions are valid in the reported 328 
temperature range.   329 
 kT25 (d-1) Θ Correlation (kT25 and Θ) 
Temperature 
range (ºC) 
COC 1.48 (1.23, 1.75) 1.07 (1.04, 1.11) 0.06 9–31 
EME 1.78 (1.03, 2.54) 1.18 (1.09, 1.28) -0.75 9–31 
CE 0.73 (0.61, 0.85) 1.10 (1.06, 1.13) 0.07 2–31 
6MAM 0.64 (0.49, 0.78) 1.04 (1.00, 1.07) 0.49 2–30 
NorCOC 1.44 (0.32, 2.57) 1.04 (0.90, 1.18) 0.29 9–31 
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